| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.6845 | 
      | Human Intestinal Absorption | HIA- | 0.5631 | 
      | Caco-2 Permeability | Caco2- | 0.8963 | 
      | P-glycoprotein Substrate | Non-substrate | 0.6976 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9659 | 
                                                     | Non-inhibitor | 0.9610 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9481 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7088 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8646 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8899 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7305 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9220 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9463 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9450 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9572 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9105 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9892 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9903 | 
                                                                    | Non-inhibitor | 0.9474 | 
      | AMES Toxicity | Non AMES toxic | 0.9327 | 
      | Carcinogens | Non-carcinogens | 0.8485 | 
      | Fish Toxicity | Low FHMT | 0.7127 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.9771 | 
      | Honey Bee Toxicity | High HBT | 0.6025 | 
      | Biodegradation | Ready biodegradable | 0.9832 | 
      | Acute Oral Toxicity | IV | 0.4722 | 
      | Carcinogenicity (Three-class) | Non-required | 0.8080 |